Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > NCF2(Gene name) > Human
  • Add your favorite
  • NCF2 (Gene name),
  • Neutrophil cytosol factor 2 (Protein name ),  NCF2_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    NCF2(NOXA2;P67PHOX);
    Protein name:
    Neutrophil cytosol factor 2(NCF-2);
    Alternative:
    NADPH oxidase activator 2;67 kDa neutrophil oxidase factor;p67-phox;Neutrophil NADPH oxidase factor 2;
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    Interacts with SYTL1 and RAC1. May interact with NOXO1.
    Function:
    NCF2, NCF1, and a membrane bound cytochrome b558 are required for activation of the latent NADPH oxidase (necessary for superoxide production).
    Subcellular Location:
    Cytoplasm
    Protein Attributes:
    Sequence length:
    526
    Sequence:
    50:
    MSLVEAISLW | NEGVLAADKK | DWKGALDAFS | AVQDPHSRIC | FNIGCMYTIL | 
    100:
    KNMTEAEKAF | TRSINRDKHL | AVAYFQRGML | YYQTEKYDLA | IKDLKEALIQ | 
    150:
    LRGNQLIDYK | ILGLQFKLFA | CEVLYNIAFM | YAKKEEWKKA | EEQLALATSM | 
    200:
    KSEPRHSKID | KAMECVWKQK | LYEPVVIPVG | KLFRPNERQV | AQLAKKDYLG | 
    250:
    KATVVASVVD | QDSFSGFAPL | QPQAAEPPPR | PKTPEIFRAL | EGEAHRVLFG | 
    300:
    FVPETKEELQ | VMPGNIVFVL | KKGNDNWATV | MFNGQKGLVP | CNYLEPVELR | 
    350:
    IHPQQQPQEE | SSPQSDIPAP | PSSKAPGRPQ | LSPGQKQKEE | PKEVKLSVPM | 
    400:
    PYTLKVHYKY | TVVMKTQPGL | PYSQVRDMVS | KKLELRLEHT | KLSYRPRDSN | 
    450:
    ELVPLSEDSM | KDAWGQVKNY | CLTLWCENTV | GDQGFPDEPK | ESEKADANNQ | 
    500:
    TTEPQLKKGS | QVEALFSYEA | TQPEDLEFQE | GDIILVLSKV | NEEWLEGECK | 
    526:
    GKVGIFPKVF | VEDCATTDLE | STRREV
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    String:
    Pfam:
    UniGene:
    SMR:
    KEGG:
    MIM:
    Uniprot:
     
    FOR
    ELISA Kit for Human NCF-2
    Cat.:
    E8769h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human NCF-2
    Cat.:
    E8769b
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    ELISA Kit for Human NCF-2
    Cat.:
    E8769r
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    ELISA Kit for Human NCF-2
    Cat.:
    E8769m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human NCF-2
    Cat.:
    U8769r
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human NCF-2
    Cat.:
    U8769b
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human NCF-2
    Cat.:
    U8769m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human NCF-2
    Cat.:
    U8769h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Polyclonal Antibody for Human NCF-2
    Cat.:
    P8769Rb-h
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human NCF-2
    Cat.:
    P8769Rb-m
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human NCF-2
    Polyclonal Antibody for Human NCF-2
    Cat.:
    P8769Rb-r
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Monoclonal Antibody for Human NCF-2
    Monoclonal Antibody for Human NCF-2
    Monoclonal Antibody for Human NCF-2
    Monoclonal Antibody for Human NCF-2
    Protein for Human NCF-2
    Protein for Human NCF-2
    Protein for Human NCF-2
    Protein for Human NCF-2

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      "Cloning of a 67-kD neutrophil oxidase factor with similarity to a noncatalytic region of p60c-src."
      Leto T.L. , Lomax K.J. , Volpp B.D. , Nunoi H. , Sechler J.M.G. , Nauseef W.M. , Clark R.A. , Gallin J.I. , Malech H.L.
      Science248:727-730(1990) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)
    2. 2.
      "Characterization of the p67phox gene: genomic organization and restriction fragment length polymorphism analysis for prenatal diagnosis in chronic granulomatous disease."
      Kenney R.T. , Malech H.L. , Epstein N.D. , Roberts R.L. , Leto T.L.
      Blood82:3739-3744(1993) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]
    3. 3.
      "Expression of a p67(phox) homolog in Caco-2 cells giving O(2)(-)-reconstituting ability to cytochrome b(558) together with recombinant p47(phox)."
      Yoshida L.S. , Nishida S. , Shimoyama T. , Kawahara T. , Rokutan K. , Tsunawaki S.
      Biochem. Biophys. Res. Commun.296:1322-1328(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1);FUNCTION;SUBUNIT;VARIANTS ARG-181; LYS-328 AND GLN-389
      tissue: Colon adenocarcinoma.
    4. 4.
      "Cloning of human full-length CDSs in BD Creator(TM) system donor vector."
      Kalnine N. , Chen X. , Rolfs A. , Halleck A. , Hines L. , Eisenstein S. , Koundinya M. , Raphael J. , Moreira D. , Kelley T. , LaBaer J. , Lin Y. , Phelan M. , Farmer A.
      Submitted (2003-05) to the EMBL/GenBank/DDBJ databases
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1);VARIANTS ARG-181 AND GLN-389
    5. 5.
      "Complete sequencing and characterization of 21,243 full-length human cDNAs."
      Ota T. , Suzuki Y. , Nishikawa T. , Otsuki T. , Sugiyama T. , Irie R. , Wakamatsu A. , Hayashi K. , Sato H. , Nagai K. , Kimura K. , Makita H. , Sekine M. , Obayashi M. , Nishi T. , Shibahara T. , Tanaka T. , Ishii S. , more...
      Nat. Genet.36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3);VARIANT ARG-181
      tissue: Umbilical cord blood.
    6. 6.
      NHLBI resequencing and genotyping service (RS&G)
      Submitted (2005-12) to the EMBL/GenBank/DDBJ databases
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]
    7. 7.
      "The DNA sequence and biological annotation of human chromosome 1."
      Gregory S.G. , Barlow K.F. , McLay K.E. , Kaul R. , Swarbreck D. , Dunham A. , Scott C.E. , Howe K.L. , Woodfine K. , Spencer C.C.A. , Jones M.C. , Gillson C. , Searle S. , Zhou Y. , Kokocinski F. , McDonald L. , Evans R. , Phillips K. , more...
      Nature441:315-321(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    8. 8.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA];VARIANT ARG-181
    9. 9.
      "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
      The MGC Project Team
      Genome Res.14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1);VARIANT ARG-181
      tissue: Lymphoma.
    10. 10.
      "JFC1, a novel tandem C2 domain-containing protein associated with the leukocyte NADPH oxidase."
      McAdara Berkowitz J.K. , Catz S.D. , Johnson J.L. , Ruedi J.M. , Thon V. , Babior B.M.
      J. Biol. Chem.276:18855-18862(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH SYTL1
    11. 11.
      "Novel human homologues of p47phox and p67phox participate in activation of superoxide-producing NADPH oxidases."
      Takeya R. , Ueno N. , Kami K. , Taura M. , Kohjima M. , Izaki T. , Nunoi H. , Sumimoto H.
      J. Biol. Chem.278:25234-25246(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH NOXO1
    12. 12.
      "The arachidonic acid-binding protein S100A8/A9 promotes NADPH oxidase activation by interaction with p67phox and Rac-2."
      Kerkhoff C. , Nacken W. , Benedyk M. , Dagher M.C. , Sopalla C. , Doussiere J.
      FASEB J.19:467-469(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH S100A8 AND CALPROTECTIN
    13. 13.
      "Full-length p40phox structure suggests a basis for regulation mechanism of its membrane binding."
      Honbou K. , Minakami R. , Yuzawa S. , Takeya R. , Suzuki N.N. , Kamakura S. , Sumimoto H. , Inagaki F.
      EMBO J.26:1176-1186(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH NCF4;DOMAIN OPR/PB1
    14. 14.
      "Structure of the TPR domain of p67phox in complex with Rac.GTP."
      Lapouge K. , Smith S.J. , Walker P.A. , Gamblin S.J. , Smerdon S.J. , Rittinger K.
      Mol. Cell6:899-907(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 1-203 IN COMPLEX WITH RAC1
    15. 15.
      "Diverse recognition of non-PxxP peptide ligands by the SH3 domains from p67(phox), Grb2 and Pex13p."
      Kami K. , Takeya R. , Sumimoto H. , Kohda D.
      EMBO J.21:4268-4276(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: STRUCTURE BY NMR OF 455-516 IN COMPLEX WITH NCF1;INTERACTION WITH NCF1
    16. 16.
      "PB1 domain-mediated heterodimerization in NADPH oxidase and signaling complexes of atypical protein kinase C with Par6 and p62."
      Wilson M.I. , Gill D.J. , Perisic O. , Quinn M.T. , Williams R.L.
      Mol. Cell12:39-50(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 352-429 IN COMPLEX WITH NCF4;SUBUNIT;CHARACTERIZATION OF VARIANT TRP-395;INTERACTION WITH NCF4
    17. 17.
      "Solution structure of the 1st SH3 domain from human neutrophil cytosol factor 2 (NCF-2)."
      RIKEN structural genomics initiative (RSGI)
      Submitted (2006-05) to the PDB data bank
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: STRUCTURE BY NMR OF 242-297
    18. 18.
      "Autosomal recessive chronic granulomatous disease with absence of the 67-kD cytosolic NADPH oxidase component: identification of mutation and detection of carriers."
      de Boer M. , Hilarius-Stokman P.M. , Hossle J.P. , Verhoeven A.J. , Graf N. , Kenney R.T. , Seger R. , Roos D.
      Blood83:531-536(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT CGD2 GLU-78
    19. 19.
      "Identification of a double mutation (D160V-K161E) (sic) in the p67phox gene of a chronic granulomatous disease patient."
      Bonizzato A. , Russo M.P. , Donini M. , Dusi S.
      Biochem. Biophys. Res. Commun.231:861-863(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT CGD2 160-GLU-VAL-161
    20. 20.
      "Molecular characterization of autosomal recessive chronic granulomatous disease caused by a defect of the nicotinamide adenine dinucleotide phosphate (reduced form) oxidase component p67-phox."
      Patino P.J. , Rae J. , Noack D. , Erickson R. , Ding J. , Garcia de Olarte D. , Curnutte J.T.
      Blood94:2505-2514(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT CGD2 19-LYS--ASP-21 DEL;VARIANTS VAL-79; ARG-181; LYS-328; GLN-389 AND TRP-395
    21. 21.
      "Autosomal recessive chronic granulomatous disease caused by novel mutations in NCF-2, the gene encoding the p67-phox component of phagocyte NADPH oxidase."
      Noack D. , Rae J. , Cross A.R. , Munoz J. , Salmen S. , Mendoza J.A. , Rossi N. , Curnutte J.T. , Heyworth P.G.
      Hum. Genet.105:460-467(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INVOLVEMENT IN CGD2;VARIANTS CGD2 GLN-77 AND VAL-128;VARIANTS ARG-181; ARG-369 AND GLN-389
    22. 22.
      "Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (first update)."
      Cross A.R. , Noack D. , Rae J. , Curnutte J.T. , Heyworth P.G.
      Blood Cells Mol. Dis.26:561-565(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT CGD2 ARG-44
    23. 23.
      "Genetic and mutational heterogeneity of autosomal recessive chronic granulomatous disease in Tunisia."
      El Kares R. , Barbouche M.R. , Elloumi-Zghal H. , Bejaoui M. , Chemli J. , Mellouli F. , Tebib N. , Abdelmoula M.S. , Boukthir S. , Fitouri Z. , M'Rad S. , Bouslama K. , Touiri H. , Abdelhak S. , Dellagi M.K.
      J. Hum. Genet.51:887-895(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT CGD2 ILE-419
    24. 24.
      "Focus on FOCIS: the continuing diagnostic challenge of autosomal recessive chronic granulomatous disease."
      Yu G. , Hong D.K. , Dionis K.Y. , Rae J. , Heyworth P.G. , Curnutte J.T. , Lewis D.B.
      Clin. Immunol.128:117-126(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS CGD2 ARG-44 AND VAL-108
    25. 25.
      "Four different NCF2 mutations in six families from Turkey and an overview of NCF2 gene mutations."
      Koker M.Y. , Sanal O. , van Leeuwen K. , de Boer M. , Metin A. , Patiroglu T. , Ozgur T.T. , Tezcan I. , Roos D.
      Eur. J. Clin. Invest.39:942-951(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS CGD2 GLU-93 AND VAL-202
    26. 26.
      "Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update)."
      Roos D. , Kuhns D.B. , Maddalena A. , Bustamante J. , Kannengiesser C. , de Boer M. , van Leeuwen K. , Koker M.Y. , Wolach B. , Roesler J. , Malech H.L. , Holland S.M. , Gallin J.I. , Stasia M.J.
      Blood Cells Mol. Dis.44:291-299(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS CGD2 SER-42; CYS-44; LYS-58 DEL; GLN-77; GLU-96 DEL; PRO-102; ARG-137; ASP-140; GLU-169; PRO-184; LYS-196 DEL AND ILE-419
    27. 27.
      "Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients."
      Koeker M.Y. , Camcioglu Y. , van Leeuwen K. , Kilic S.S. , Barlan I. , Yilmaz M. , Metin A. , de Boer M. , Avcilar H. , Patiroglu T. , Yildiran A. , Yegin O. , Tezcan I. , Sanal O. , Roos D.
      J. Allergy Clin. Immunol.132:1156-1163(2013) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS CGD2 GLU-93 AND VAL-202
    Product Feedback Wall
    Hot Genes
    Atf2 ASPRO ACE ALCAM C19orf80 Trap1a Gdf5
    Top Searches
    Ubiquitin-protein ligase metalloproteinase Ubiquitin ELISA Alpha Tumor necrosis Asprosin TRAP1A
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2026 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter